You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

Xpert Xpress SARS-CoV-2 Test

Oncology/Genetics

Cepheid is expanding its Oncology portfolio to deliver life-changing technology to physicians and their cancer patients globally. We also offer a rapid test that detects the genetic risk for thrombosis.

Products

Xpert® BCR-ABL Ultra

Sensitive and quantitative monitoring of BCR-ABL mRNA in patients with chronic myelogenous leukemia (CML)

Learn More


Xpert® Bladder Cancer Detection

Detection of the presence of bladder cancer in patients with hematuria in 90 minutes 

Learn More


Xpert® Bladder Cancer Monitor

Qualitative monitoring for recurrence in patients previously diagnosed with bladder cancer in 90 minutes

Learn More


Xpert® Breast Cancer STRAT4

Semi-quantitative measurement of ESR1, PGR, ERBB2, and MKi67 from FFPE invasive breast cancer tissue in 2 hours

Learn More


Xpert® FII & FV

30 Minute test for genetic risk of Thrombosis

Learn More


CE-IVD. In Vitro Diagnostic Medical Device. Not available in all countries.
Back to Top